UbiVac

About:

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer.

Website: https://www.ubivac.com/

Description:

UbiVac is a clinical-stage biotechnology company engaged in the research and development of therapeutic vaccines to combat cancer. Founded in Portland, OR in 2005 as a spinout of the Robert W. Franz Cancer Research Center within the Earle A. Chiles Research Institute, at Providence Portland Medical Center, UbiVac continues to build upon the groundbreaking research being developed in the region.

Total Funding Amount:

$2.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Portland, Oregon, United States

Founded Date:

2005-01-01

Founders:

Bernard A. Fox

Number of Employees:

1-10

Last Funding Date:

2022-04-14

IPO Status:

Private

Industries:

© 2025 bioDAO.ai